Literature DB >> 9135167

Importance of delivery systems for growth-stimulatory factors in combination with osteopromotive membranes. An experimental study using rhBMP-2 in rat mandibular defects.

G Zellin1, A Linde.   

Abstract

This study was undertaken to investigate whether the choice of carrier/delivery system might be crucial for rhBMP-2 induced osteogenesis beneath osteopromotive membranes. Standardized 5-mm transosseous rat mandibular defects were implanted with recombinant human BMP-2 (rhBMP-2) with or without membrane placement. Two doses of rhBMP-2 (1 microg and 8 microg per defect) were delivered with either collagen sponge or bioabsorbable poly(D,L-lactide-coglycolide) (PLA/PGA) beads plus allogenic blood as carriers. Membrane-covered defects (no BMP) served as controls. Virtually all defects treated with rhBMP-2 without membrane placement already were bridged by new bone after 12 days, independent of rhBMP-2 dose or carrier material, and lateral bone growth was extensive outside the original defect. Membrane placement significantly decreased the stimulatory activity of the BMP, as seen after 12 days, even though osteogenesis was more advanced with rhBMP-2 and membrane compared to membrane alone. After 24 days, defects treated with membrane and rhBMP-2 in the PLA/PGA carrier were totally bridged with regenerated bone, whereas defects covered with membrane without BMP implantation displayed an average bone bridging of only 53%. In an overall analysis of the bone regeneration, the PLA/PGA carrier material was found to be superior to the collagen carrier in the presence of membranes, which was, in turn, more efficient than membrane placement alone (no rhBMP-2). There was much less lateral bone growth when BMP implantation was combined with membrane placement. It was concluded that bone formation beneath osteopromotive membranes may be significantly enhanced by rhBMP-2 and that the delivery system can affect the amount of bone formation obtained. For eventual clinical use, membrane placement has the advantage of keeping the growth-stimulatory implant in place as well as obtaining the desired anatomical contour of the bone formed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135167     DOI: 10.1002/(sici)1097-4636(199705)35:2<181::aid-jbm6>3.0.co;2-j

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  15 in total

Review 1.  Growth factor delivery for tissue engineering.

Authors:  J E Babensee; L V McIntire; A G Mikos
Journal:  Pharm Res       Date:  2000-05       Impact factor: 4.200

Review 2.  Growth factor delivery for oral and periodontal tissue engineering.

Authors:  Darnell Kaigler; Joni A Cirelli; William V Giannobile
Journal:  Expert Opin Drug Deliv       Date:  2006-09       Impact factor: 6.648

3.  Effect of targeted delivery of bone morphogenetic protein-2 on bone formation in type 1 diabetes.

Authors:  Ronaldo Barcellos de Santana; Phillip C Trackman
Journal:  Int J Oral Maxillofac Implants       Date:  2015 May-Jun       Impact factor: 2.804

4.  Recombinant biglycan promotes bone morphogenetic protein-induced osteogenesis.

Authors:  P A Miguez; M Terajima; H Nagaoka; J A R Ferreira; K Braswell; C C Ko; M Yamauchi
Journal:  J Dent Res       Date:  2014-01-30       Impact factor: 6.116

Review 5.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.

Authors:  Aaron W James; Gregory LaChaud; Jia Shen; Greg Asatrian; Vi Nguyen; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Tissue Eng Part B Rev       Date:  2016-04-19       Impact factor: 6.389

6.  Bone morphogenetic protein-2-impregnated biomimetic scaffolds successfully induce bone healing in a marginal mandibular defect.

Authors:  Adam S DeConde; Douglas Sidell; Min Lee; Olga Bezouglaia; Kyle Low; David Elashoff; Tristan Grogan; Sotirios Tetradis; Tara Aghaloo; Maie St John
Journal:  Laryngoscope       Date:  2013-04-02       Impact factor: 3.325

7.  Role of glycosaminoglycans of biglycan in BMP-2 signaling.

Authors:  P A Miguez; M Terajima; H Nagaoka; Y Mochida; M Yamauchi
Journal:  Biochem Biophys Res Commun       Date:  2011-01-08       Impact factor: 3.575

8.  The effect of immobilization of heparin and bone morphogenic protein-2 to bovine bone substitute on osteoblast-like cell's function.

Authors:  Jung-Bo Huh; Sung-Eun Kim; Se-Kyung Song; Mi-Jung Yun; Ji-Suk Shim; Jeong-Yol Lee; Sang-Wan Shin
Journal:  J Adv Prosthodont       Date:  2011-09-25       Impact factor: 1.904

Review 9.  The role of barrier membranes for guided bone regeneration and restoration of large bone defects: current experimental and clinical evidence.

Authors:  Rozalia Dimitriou; George I Mataliotakis; Giorgio Maria Calori; Peter V Giannoudis
Journal:  BMC Med       Date:  2012-07-26       Impact factor: 8.775

10.  Bone formation in a rat tibial defect model using carboxymethyl cellulose/BioC/bone morphogenic protein-2 hybrid materials.

Authors:  Sang-Heon Song; Young-Pil Yun; Hak-Jun Kim; Kyeongsoon Park; Sung Eun Kim; Hae-Ryong Song
Journal:  Biomed Res Int       Date:  2014-04-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.